Gene-nutrient interaction and its association with obesity and diabetes mellitus;Interação entre gene e nutriente e sua associação à obesidade e ao diabetes melito

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 53, Issue 5, 2009, Pages 497-508

  Steemburgo, Thais ^a,b   de Azevedo, Mirela J ^a   Martínez, José Alfredo ^b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Diabetes mellitus; Interaction gene nutrient; Obesity; Polymorphisms

Indexed keywords

ARTICLE; CHRONIC DISEASE; DIABETES MELLITUS; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HUMAN; NUTRIGENOMICS; OBESITY; PHENOTYPE;

CHRONIC DISEASE; DIABETES MELLITUS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NUTRIGENOMICS; OBESITY; PHENOTYPE; POLYMORPHISM, GENETIC;

EID: 70349956377     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/s0004-27302009000500003     Document Type: Article

References (74)

1. Ordovas JM, Mooser V. Nutrigenomics and nutrigenetics. Curr Opin Lipidol. 2004;15(2):101-8.
2. van Ommen B. Nutrigenomics: exploiting systems biology in the nutrition and health arenas. Nutrition. 2004;20(1):4-8.
3. Müller M, Kersten S. Nutrigenomics: goals and strategies. Nat Rev Genet. 2003;4(4):315-22.
4. Corthésy-Theulaz I, den Dunnen JT, Ferré P, Geurts JMW, Müller M, van Belzen N, et al. Nutrigenomics: the impact of biomics technology on nutrition research. Ann Nutr Metab. 2005;49(6):355-65.
5. Afman L, Müller M. Nutrigenomics: from molecular nutrition to prevention of disease. J Am Diet Assoc. 2006;106(4):569-76.
6. Gillies PJ. Nutrigenomics: the Rubicon of molecular nutrition. J Am Diet Assoc. 2003;103(12 Suppl 2):S50-5.
7. Ordovas JM, Corella D, Demissie S, Cupples A, Couture P, Coltell O, et al. Dietary fat intake determines the effect of a common polymorphism in the hepatic lipase gene promoter on high-density lipoprotein metabolism. Evidence of a strong dose effect in this gene-nutrient interaction in the Framingham Study. Circulation. 2002;106(18):2315-21.
8. Ordovas JM, Corella D, Cupples LA, Demissie LA, Kelleher A, Coltell O, et al. Polyunsaturated fatty acids modulate the effects of the APOA1 G-A polymorphism on HDL-cholesterol concentrations in a sex-specific manner: the Framingham Study. Am J Clin Nutr. 2002;75(1):38-46.
9. Robitaille J, Pérusse L, Vohl MC. The PPAR-gama P12A polymorphism modulate the relationship between dietary fat intake and components of the metabolic syndrome: results from the Québec Family Study. Clin Genet. 2003;63(2):109-16.
10. Robitaille J, Gaudet D, Pérusse L, Vohl MC. Features of the metabolic syndrome are modulated by an interaction between the peroxisome proliferator-actived receptor-delta -87T > C polymorphism and dietary fat in French-Canadians. Int J Obes (Lond). 2007;31(3):411-7.
11. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047-53.
12. Maes HH, Neale MC, Eaves LJ. Genetic and enviromental factors in relative body weight and human obesity. Behav Genet. 1997;27(4):325-51.
13. Abelson P, Kennedy D. The obesity epidemic. Science. 2004;304(5676):1413.
14. Wareham NJ, Franks PW, Harding AH. Establishing the role of gene-enviroment interactions in the etiology of type 2 diabetes. Endocrinol Metab Clin. 2002;31(3):553-66.
15. Goyenechea E, Parra D, Martinez JA. Impact of interleukin 6-174G > C polymorphism on obesity-related metabolic disorders in people with excess in body weight. Metab Clin Experim. 2007;56(12):1643-8.
16. Möhlig M, Boeing H, Spranger J, Osterhoff M, Kroke A, Fisher E, et al. Body Mass Index and C-174G Interleukin-6 promoter polymorphism interact in predicting type 2 diabetes. J Clin Endocrinol Metab. 2004;89(4):1885-9.
17. Stephens JW, Hurel SJ, Lowe GDO, Rumbley A, Humphries SE. Association between plasma IL-6, the IL-6 -174G > C gene variant and metabolic syndrome in type 2 diabetes mellitus. Mol Gene Metabol. 2007;90(4):422-8.
18. Song Y, Miyaki K, Araki J, Zhang L, Omae K, Muramatsu M. The interaction between the interleukin 6 receptor gene genotype and dietary energy intake on abdominal obesity in Japanese men. Metabolism Clin Exp. 2007;56(7):925-30.
19. Goyenechea E, Dolores Parra M, Alfredo Martínez J. Weight regain after slimming induced by an energy-restricted diet depends on interleukin-6 and peroxisome-proliferator-activated-receptor-γ2 gene polymorphism. Br J Nutr. 2006;96(5):965-72.
20. Stumvoll M, Häring H. The peroxisome proliferator-activated receptor-γ2 pro12 ala polymorphism. Diabetes. 2002;51(8):2341-7.
21. Frederiksen L, Brødbaek K, Fenger M, Jørgensen T, Borch-Johnsen K, Madsbad S, et al. Comment: studies of the Pro12Ala polymorphism of the PPAR-gamma gene in the Danish MONICA cohort: homozygosity of the Ala allele confers a decreased risk of the insulin resistance syndrome. J Clin Endocrinol Metab. 2002;87(8):3989-92.
22. Mori H, Ikegami H, Kawaguchi Y, Seino S, Yokoi N, Takeda J, et al. The Pro12→ Ala substitution in PPAR-γ is associated with resistance to development of diabetes in the general population. Possible involvement in impairment of insulin secretion in individuals with type 2 diabetes. Diabetes. 2001;50(4):891-4.
23. Pisabarro RE, Sanguinetti C, Stoll M, Prendez D. High incidence of type 2 diabetes in peroxisome proliferators-actived receptor γ2 Pro12Ala carries exposed to a high chronic intake of trans fatty acids and saturated fatty acids. Diabetes Care. 2004;27(9):2251-2.
24. Lindi VI, Uusitupa MIJ, Lindströn J, Louheranta A, Eriksson JG, Valle TT, et al. Association of the Pro12Ala polymorphism in the PPAR-γ2 with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study Group. Diabetes. 2002;51(8):2581-6.
25. Ylönen SK, Salminen I, Lyssenko V, Virtanen S, Groop L, Aro A, et al. The Pro12Ala polymorphism of the PPAR-γ2 gene affects associations of fish intake and marine n-3 fatty acids with glucose metabolism. Eur J Clin Nutr. 2008;62(12):1432-9.
26. Memisoglu A, Hu FB, Hankinson SE, Manson JE, De Vivo I, Willett WC, et al. Interaction between a peroxisome proliferator-activated receptor γ gene polymorphism and dietary fat intake in relation to body mass. Hum Mol Genet. 2003;12(22):2923-9.
27. Nelson TL, Fingerlin TE, Moss L, Barmada MM, Ferrell RE, Norris JM. The PPAR-γ Pro12Ala polymorphism is not associated with body mass index or waist circumference among Hispanics from Colorado. Ann Nutr Metab. 2007;51(3):252-7.
28. Large V, Hellström L, Reynisdottir S, Lönnqvist F, Eriksson P, Lannfelt L, et al. Human beta-2 adrenoreceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoreceptor function. Clin Invest. 1997;100(12):3005-13.
29. Martínez JA, Corbalán MS, Sánchez-Villegas A, Forga L, Marti A, Martínez-González MA. Obesity risk is associated with carbohydrate intake in women carrying the Gln27Glu β2-Adrenoceptor polymorphism. J Nutr. 2003;133(8):2549-54.
30. Boss O, Muzzin P, Giacobino JP. The uncoupling proteins, a review. Eur J Endocrinol. 1998;139:1-9.
31. Dalgaard LT, Pedersen O. Uncoupling proteins: functional characteristics and role in the pathogenesis of obesity and Type II diabetes. Diabetologia. 2001;44(8):946-65.
32. Marti A, Corbalán MS, Forga L, Martinez-Gonzales MA, Martinez JA. Higher obesity risk associated with the exon 8 insertion allele of the UCP2 gene in a Spanish case-control study. Nutrition. 2004;20(6):498-501.
33. Kim OY, Cho EY, Park HY, Jang T, Lee JH. Additive effect of the mutations in the β3-adrenoreceptor gene and UCP3 gene promoter on body fat distribution and glycemic control after weigth reduction in overweigth subjetcs with CAD or metabolic syndrome. In J Obes. 2004;28(3):434-41.
34. Cha MH, Shin HD, Kim KS, Lee BH, Yoon Y. The effects of uncoupling protein 3 haplotypes on obesity phenotypes and very lowenergy diet-induced changes among overweight Korean female subjects. Metabolism. 2006;55(5):578-86.
35. Heo M, Leible RL, Boyer BB, Chung WK, Koulu M, Karvonen MMK, et al. Pooling analysis of genetic data: the association of leptin receptor (LEPR) polymorphisms with variables related to human adiposity. Genetics. 2001;159(3):1163-78.
36. Clément K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, Gourmelen M. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature. 1998;329(6674):398-401.
37. de Luis Roman D, de la Fuente RA, Sagrado MG, Izaola O, Vicente RC. Leptin receptor Lys656Asn polymorphism is associated with decreased leptin response and weight loss secondary to a lifestyle modification in obese patients. Arch Med Res. 2006;37(7):854-9.
38. de Luis DA, Aller R, Izaola O, Sagrado MG, Conde R. Influence of Lys656Asn polymorphism of leptin receptor gene on leptin response secondary to two hypocaloric diets: a randomized clinical trial. Ann Nutr Metab. 2008;52(3):209-14.
39. Schwartz MW, Woods SC, Porte D, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature. 2000;404(6778):661-7.
40. Young EH, Wareham NJ, Farooqi S, Hinney A, Hebebrand J, Scherag A, et al. The V1031I polymorphism of the MC4R gene and obesity: population based studies and meta-analysis of 29 563 individuals. In J Obes (Lond). 2007;31(9):1437-41.
41. Pichler M, Kollerits B, Heid IM, Hunt SC, Adams TD, Hopkins PN, et al. Association of the melanocortin-4 receptor V1031I polymorphism with dietary intake in several obese persons. Am J Clin Nutr. 2008;88(3):797-800.
42. Feng N, Young SF, Aguilera G, Puricelli E, Adler-Wailes DC, Sebring NG, et al. Co-occurrence of two partially inactivating polymorphism of MC3R is associated with pediatric-onset obesity. Diabetes. 2005;54(9):2663-7.
43. Santoro N, Perrone L, Cirillo G, Raimondo P, Amato A, Brienza C, et al. Effect of the melanocortin-3 receptor C17A and G241A variants on weight loss in childhood obesity. Am J Clin Nutr. 2007;85(4):950-3.
44. Hunt SC, Stone S, Xin Y, Scherer CA, Magness CL, Iadonato SP, et al. Association of the FTO gene with BMI. Obesity (Silver Spring). 2008;16(4):902-4.
45. Hota K, Nakata Y, Matsuo T, Kamohara S, Kotani K, Komatsu R, et al. Variations in the FTO gene are associated with severe obesity in the Japanese. J Hum Genet. 2008; 53(6):546-53.
46. Yajnik CS, Janipalli CS, Bhaskar S, Kulkarni SR, Freathy RM, Prakash S, et al. FTO gene variants are strongly associated with type 2 diabetes in South Asian Indians. Diabetologia. 2009;52(2):247-52.
47. Chang YC, Liu PH, Lee WJ, Chang TJ, Jiang YD, Li HU, et al. Common variations in the FTO gene confers risk of obesity and modulates body mass index in the Chinese population. Diabetes. 2008;57(8):2245-52.
48. Frayling TM, Tipmson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM. A common variant in the FTO gene is associated with Body Mass Index and predisposes to childhood and adult obesity. Science. 2007;316(5826):889-93.
49. Al-Attar S, Pollex RL, Ban MR, Young TK, Bjerreggard P, Anand SS, et al. Association between the FTO rs9939609 polymorphism and the metabolic syndrome in a non-Caucasian multi-ethnic sample. Cardiovasc Diabetol. 2008;7:5.
50. Wardle J, Carnell S, Haworth CMA, Farooqi SI, O'Rahilly S, Plomin R, et al. Obesity-associated genetic variation in FTO associated with diminished satiety. J Clin Endocrinol Metab. 2008;93(9):3640-3.
51. Timpson NJ, Emmett PM, Frayling TM, Rogers I, Hattersley AT, McCarthy MI, et al. The fat massand obesity associated locus and dietary intake in children. Am J Clin Nutr. 2008;88(4):971-8.
52. Thuren T. Hepatic lipase and HDL metabolism. Curr Opion Lipidol. 2000;11(3):277-83.
53. Cohen JC, Vega GL, Grundy SM. Hepatic lipase: new insights from genetics and metabolics studies. Curr Opion Lipidol. 1999;10(3):259-67.
54. Tai ES, Corella D, Deurenberg-Yap M, Cutter J, Chew SK, Ordovas J. Dietary fat interacts with the -514C > T polymorphism in the hepatic lipase gene promoter on plasma lipid profiles in a multiethnic Asian population: the 1998 Singapore National Health Survey. J Nutr. 2003;133(11):3399-408.
55. Zhang C, Lopez-Ridaura Rl, Rimm EB, Rifai N, Hunter DJ, Hu FB. Interactions between the -514C→T polymorphism of the hepatic lipase gene and lifestyle factors in relation to HDL concentrations among US diabetic men. Am J Clin Nutr. 2005;81(6):1429-35.
56. Santos JL, Boutin P, Verdich C, Holst C, Larsen LH, Toubro S, et al. Genotype-by-nutrient interactions assessed in European obese women. A case-only study. Eur J Nutr. 2006;45(8):454-62.
57. Havel PJ. Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. Diabetes. 2004;53 Suppl 1:Sl43-51.
58. Ohashi K, Ouchi N, Kihara S, Funahashi T, Nakamura T, Sumitsuji S, et al. Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease. J Am Coll Cardiol. 2004;43(7):1195-200.
59. Menzaghi C, Trischitta V, Doria A. Genetics influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease. Diabetes. 2007;56(6):1198-209.
60. Vasseur F, Helbecque N, Dina C, Lobbens S, Delannoy V, Gagetet S, et al. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for the type 2 diabetes in French Caucasians. Hum Mol Genet. 2002;11(21):2607-14.
61. Hara K, Boutin P, Mori Y, Tobe K, Dina C, Yasuda K, et al. Genetic variation in the gene enconding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes. 2002;51(2):536-40.
62. Pérez-Martínez P, Lópes-Miranda J, Cruz-Teno C, Delgado-Lista J, Jimenez-Gómez Y, Fernández JM, et al. Adiponectin gene variants are associated with insulin sensitivity in response to dietary fat consumption in Caucasian men. J Nutr. 2008;138(9):1609-14.
63. Goyenechea E, Collins LJ, Parra D, Abete I, Crujeiras AB, Martinez JA, et al. The -11391 G/A polymorphism of the adiponectin gene promoter is associated with metabolic syndrome traits and the outcome of an energy-restricted diet in obese subjects. Horm Metab Res. 2009;41(1):55-61.
64. Puigserver P, Spielgelman BM. Peroxisome proliferators-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocrinol Rev. 2003;24(1):78-90.
65. Hara K, Tobe K, Okada T, Kadowaki H, Akanuma Y, Ito C, et al. A genetic variation in the PGC-1 gene could confer insulin resistance and susceptibility to Type II diabetes. Diabetologia. 2002;45(5):740-3.
66. Esterbauer H, Oberkofler H, Linnemayr V, Iglseder B, Hedegger M, Wolfsgruber P, et al. Peroxisome proliferators-activated receptorgamma coactivator-1 gene locus: association with obesity indices in middle-age women. Diabetes. 2002;51(4):1281-6.
67. Goyenechea E, Crujeiras AB, Abete I, Parra D, Martinez JA. Enchanced short-term improvement of insulin response to a lowcalorie diets in obese carries the Gly482Ser variant of the PGC-1α gene. Diab Res Clin Pract. 2008;82(2):190-6.
68. Marín C, Pérez-Jiménez F, Gómez P, Delgado J, Paniagua JA, Lozano A, et al. The Ala54Thr polymorphis55m of the fatty acidbinding protein 2 gene is associated with a change in insulin sensitivity after a change in the type of dietary fat. Am J Clin Nutr. 2005;82(1):196-200.
69. Agren JJ, Vidgren HM, Valve RS, Laakso M, Uusitupa MI. Postprandial responses of individual fatty acids in subjects homozygous for the threonine-or alanine-encoding allele in codon 54 of the intestinal fatty acid binding protein 2 gene. Am J Clin Nutr. 2001;73(1):31-5.
70. Canani LH, Capp C, Ng DP, Choo SG, Maia AL, Nabinger GB, et al. The fatty acid-binding protein-2 A54T polymorphism is associated with renal disease in patients with type 2 diabetes. Diabetes. 2005;54(11):3326-30.
71. Georgopoulos A, Aras O, Tsai MY. Codon-54 polymorphism of the fatty acid-binding protein 2 gene is associated with elevation of fasting and postprandial triglyceride in type 2 diabetes. J Clin Endocrinol Metab. 2000;85(9):3155-60.
72. Almeida JC, Franzosi O, Moraes FS, Morelatto A, Perassolo MS, Canani LH, et al. A polymorphism at codon 54 (Ala54Thr) in the FABP2 gene influences the postprandial serum fatty acids after standard meal in type 2 diabetic patients. American Diabetes Association's 68th Annual Meeting, June 6 June 10, 2008, San Francisco, USA.
73. Laakso M, Kesäniemi A, Kervinen K, Jauhiainen K, Jauhiainen M, Pyorala L. Relation of coronary heart disease and apolipoprotein E phenotype in patients with non-insulin dependent diabetes mellitus. BMJ. 1991;303(6811):1159-62.
74. Moreno JA, Pérez-Jiménez, Marín C, Pérez-Martínez P, Moreno R, Gómez P, et al. The apoliprotein E gene promoter (-129G/T) polymorphism determines insulin sensitivity in response to dietary fat in healthy young adults. J Nutr. 2005;135(11):2535-40.